title: Transplant accommodation--are the lessons learned from xenotransplantation pertinent for clinical allotransplantation?
abstract: "Accommodation" refers to a vascularized transplant that has acquired resistance to antibody-mediated rejection (AMR). The term was coined in 1990, but the phenomenon was first described after clinical ABO-incompatible (ABOi) renal transplantation in the 1980s and is recognized as a common outcome in this context today. Because of the absence, until recently of reliable animal models of allograft accommodation, it has been studied extensively by investigators in the xenotransplantation field. With recent advances in the ability to recognize and diagnose AMR in human organs, the growth of desensitization programmes for transplantation into sensitized recipients and the availability of therapies that have the potential to promote accommodation, it is timely to review the literature in this area, identifying lessons that may inform preclinical and clinical studies in the future.
authors: Medical Research Council Centre for Transplantation & Innate Immunity Section, Division of Transplantation Immunology and Mucosal Biology, King's College London, Guy's Hospital, Great Maze Pond, London, UK.
authors: A
authors: A
authors: Dorling
mesh_terms: D000818:Animals; D001787:Blood Group Incompatibility / Q000517:prevention & control*; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D014181:Transplantation Immunology / Q000276:immunology*; D014183:Transplantation, Heterologous / Q000276:immunology*; D014184:Transplantation, Homologous